In support, salicylate, a direct AMPKβ1 activator, has been recently proven to be therapeutically effective in ameliorating inflammation in DSS-induced colitis by the activation of macrophage autophagy through an AMPK-dependent mechanism [60]. The gene discussed is PRKAA2; the disease is colitis.